Figure 1:
Bilateral eye findings in 40 year old woman with systemic lupus erythematosus on hydroxychloroquine for 10 years. Fundus photos (a and b) depict advanced bull's eye maculopathy in both eyes (arrow). Significantly decreased autofluorescence centrally with surrounding hyperfluorescence highlights marked retinal pigment epithelium and photoreceptor loss (c and d). Spectral domain optical coherence tomography imaging (e and f) demonstrates significant parafoveal outer retinal segment loss (arrow) and consequent "flying saucer sign" (between arrows). maculopathy bilaterally with significant outer retinal segment loss. Although retinal toxicity from hydroxychloroquine is rare, vision loss due to maculopathy is often irreversible and can be progressive. Despite the patient's daily dose of the recommended <5 mg/kg, her use of the medication for 10 years, coupled with a cumulative dose of 1460 g, increased her risk for hydroxychloroquine-related toxicity. Recommendation for immediate cessation of the hydroxychloroquine was communicated to the patient's rheumatologist. American Academy of Ophthalmology recommends baseline and annual
Combined central retinal vein occlusion and branch retinal artery occlusion
A 66-years-old female was diagnosed to have combined central retinal vein occlusion (CRVO) and branch retinal artery occlusion (BRAO). Colour fundus photograph [ Fig. 1a] showing multiple haemorrhages and pale ischaemic area superiorly (black arrow). In Fig. 1b, fundus fluorescein angiography (FFA) shows delayed arterial filling and prolonged arteriovenous transit time. Multicolour imaging highlights the area of ischaemia (black arrow) and serous fluid in macular area as dark green as shown in Fig. 1c. In Fig. 1d and e, optical coherence tomography shows hyper-reflectivity of inner retinal layers (red arrow) and serous detachment (star), respectively.
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